30692362|t|[A Case of Advanced Esophageal Cancer Successfully Treated with Neoadjuvant Chemotherapy Containing 5-FU, Docetaxel. and Nedaplatin Combination Therapy].
30692362|a|A 71-year-old man with a history of hypertension, diabetes mellitus, and cerebral infarction was admitted to our hospital with dysphagia. Gastroduodenoscopy, thoracoabdominal CT, and PET-CT findings showed type 2 advanced esophageal cancer( squamous cell carcinoma)with upper mediastinal and cervical lymph node(LN)metastasis: cT3N2M1(LYM #104L), cStage IV. Two courses of neoadjuvant UDONchemotherapy containing 5-FU(640mg/m / 2, days 1-5), docetaxel(28mg/m2, days 1 and 15), and nedaplatin(72mg/m2, day 1)were administered every 4 weeks. UDONtherapy caused grade(Gr)3 febrile neutropenia, Gr 2 diarrhea, and Gr 1 thrombopenia; the tumor and LNs partially responded to the therapy. After 2 courses of UDONtherapy, esophagectomy with right thoracotomy, 3-field LNdissection, and reconstruction of the gastric tube were performed. The postoperative course was almost uneventful besides recurrent nerve palsy, aspiration, pneumonia, and delirium, and the patient was discharged 60 days after surgery. The pathological diagnosis was ypT0N0M0, ypStage 0, and the histological response of the primary tumor and LNs were evaluated as Gr 3. Neoadjuvant UDON therapy is feasible for elderly patients with advanced esophageal cancer and renal failure or comorbidities, for whom CDDP could not be administered. We are planning a clinical trial to assess the effectiveness of neoadjuvant UDONtherapy.
30692362	20	37	Esophageal Cancer	Disease	MESH:D004938
30692362	100	104	5-FU	Chemical	MESH:D005472
30692362	106	115	Docetaxel	Chemical	MESH:D000077143
30692362	121	131	Nedaplatin	Chemical	MESH:C053989
30692362	168	171	man	Species	
30692362	190	202	hypertension	Disease	MESH:D006973
30692362	204	221	diabetes mellitus	Disease	MESH:D003920
30692362	227	246	cerebral infarction	Disease	MESH:D002544
30692362	281	290	dysphagia	Disease	MESH:D003680
30692362	376	393	esophageal cancer	Disease	MESH:D004938
30692362	395	418	squamous cell carcinoma	Disease	MESH:D002294
30692362	455	479	lymph node(LN)metastasis	Disease	MESH:D008207
30692362	481	488	cT3N2M1	Disease	
30692362	489	498	LYM #104L	CellLine	CVCL:4859
30692362	501	510	cStage IV	Disease	MESH:D006011
30692362	567	571	5-FU	Chemical	MESH:D005472
30692362	596	605	docetaxel	Chemical	MESH:D000077143
30692362	635	645	nedaplatin	Chemical	MESH:C053989
30692362	694	705	UDONtherapy	Chemical	-
30692362	724	743	febrile neutropenia	Disease	MESH:D064147
30692362	750	758	diarrhea	Disease	MESH:D003967
30692362	769	781	thrombopenia	Disease	MESH:D013921
30692362	787	792	tumor	Disease	MESH:D009369
30692362	856	867	UDONtherapy	Chemical	-
30692362	1039	1060	recurrent nerve palsy	Disease	MESH:D014826
30692362	1062	1072	aspiration	Disease	MESH:D011015
30692362	1074	1083	pneumonia	Disease	MESH:D011014
30692362	1089	1097	delirium	Disease	MESH:D003693
30692362	1107	1114	patient	Species	9606
30692362	1250	1255	tumor	Disease	MESH:D009369
30692362	1300	1304	UDON	Disease	
30692362	1337	1345	patients	Species	9606
30692362	1360	1377	esophageal cancer	Disease	MESH:D004938
30692362	1382	1395	renal failure	Disease	MESH:D051437
30692362	1423	1427	CDDP	Chemical	-
30692362	1531	1542	UDONtherapy	Chemical	-
30692362	Negative_Correlation	MESH:D000077143	MESH:D006011
30692362	Cotreatment	MESH:C053989	MESH:D005472
30692362	Cotreatment	MESH:C053989	MESH:D000077143
30692362	Positive_Correlation	MESH:D005472	MESH:D064147
30692362	Negative_Correlation	MESH:D005472	MESH:D004938
30692362	Negative_Correlation	MESH:D000077143	MESH:D009369
30692362	Positive_Correlation	MESH:D000077143	MESH:D003967
30692362	Cotreatment	MESH:D000077143	MESH:D005472
30692362	Negative_Correlation	MESH:D005472	MESH:D006011
30692362	Negative_Correlation	MESH:C053989	MESH:D004938
30692362	Negative_Correlation	MESH:D000077143	MESH:D004938

